Evaluating an instant assessment feedback tool among cannabis users referred to treatment.

Not Applicable

Completed

• Conditions: cannabis dependence; Mental Health - Addiction

• Registration Number: ACTRN12617000995370
• Lead Sponsor: Matthew Gullo

Brief Summary

Psychological assessment and personalised feedback are important components of brief interventions (BIs) for cannabis use. The diversity of assessment instruments and time burden associated with scoring them pose a challenge for effective implementation in clinical practice. An instant assessment and feedback (iAx) system was developed to administer bioSocial Cognitive Theory (bSCT) assessments that were instantly benchmarked against clinical norms to inform treatment planning. This study evaluated the additive effectiveness of the iAx system compared to treatment as usual in a single-session BI using a Randomised Controlled Trial (RCT). Eighty-seven patients were randomly assigned to the single-session BI utilising the iAx system (iAx; n = 44) or the standard single-session BI (treatment-as-usual [TAU]; n = 43). Participants allocated to iAx experienced a greater increase in motivation to change from pre- to post-treatment in comparison to participants allocated to TAU. However, the addition of the iAx was not associated with greater patient satisfaction, which was high in both conditions. In conclusion, the addition of a new theory-driven iAx assessment system increased motivation to change cannabis use during a single-session BI delivered within a large public hospital system.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-07-11
• Study Completion: 2018-08-31
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 87

Inclusion Criteria

Patients who present for a cannabis assessment session at the location of this study are eligble for inclusion.

Exclusion Criteria

Patients with severe cognitive impairment or a comorbid mental health disorder that is assessed by the clinician as potentially impairing their decision making will be automatically excluded from the study and offered treatment as usual.

Patients under the age of 18 may be excluded from the study if the clinician believes they are emotionally or cognitively incompetent to make an informed decision to paticipant. These patients will be offered treatment as usual.

Study & Design

• Study Type: Interventional
• Study Design: Not specified